Lewis Au

4.9k total citations · 1 hit paper
30 papers, 396 citations indexed

About

Lewis Au is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Lewis Au has authored 30 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Lewis Au's work include Cancer Immunotherapy and Biomarkers (18 papers), CAR-T cell therapy research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Lewis Au is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), CAR-T cell therapy research (6 papers) and Colorectal Cancer Treatments and Studies (5 papers). Lewis Au collaborates with scholars based in United Kingdom, Australia and Germany. Lewis Au's co-authors include James Larkin, Samra Turajlic, Robert M. Mason, Alvaro Ingles Garces, Jayesh Desai, Thiago M. Steiner, Lillian L. Siu, Elena Garralda, Jennifer Thomas and Martin Gore and has published in prestigious journals such as Cell, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

Lewis Au

26 papers receiving 394 citations

Hit Papers

Bispecific antibodies: advancing precision oncology 2024 2026 2025 2024 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lewis Au United Kingdom 11 267 88 86 81 52 30 396
Santiago Aparo United States 11 238 0.9× 59 0.7× 42 0.5× 97 1.2× 64 1.2× 30 391
Jean David Fumet France 7 347 1.3× 87 1.0× 140 1.6× 85 1.0× 31 0.6× 14 409
Adam Diehl United States 7 221 0.8× 54 0.6× 54 0.6× 69 0.9× 44 0.8× 16 299
Thiagarajan Sreenivasan United Kingdom 6 208 0.8× 139 1.6× 52 0.6× 126 1.6× 57 1.1× 6 808
David Casadevall Spain 9 233 0.9× 69 0.8× 60 0.7× 134 1.7× 116 2.2× 31 383
Veronica Lonati Italy 8 246 0.9× 71 0.8× 34 0.4× 110 1.4× 96 1.8× 11 364
Elizabeth C. Paver Australia 7 186 0.7× 82 0.9× 51 0.6× 76 0.9× 47 0.9× 15 322
Wang‐Zhong Li China 13 275 1.0× 61 0.7× 58 0.7× 116 1.4× 71 1.4× 41 523
Lucia Bonomi Italy 8 256 1.0× 113 1.3× 66 0.8× 220 2.7× 36 0.7× 23 433
B. Tiangco Philippines 11 255 1.0× 85 1.0× 41 0.5× 183 2.3× 78 1.5× 21 495

Countries citing papers authored by Lewis Au

Since Specialization
Citations

This map shows the geographic impact of Lewis Au's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lewis Au with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lewis Au more than expected).

Fields of papers citing papers by Lewis Au

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lewis Au. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lewis Au. The network helps show where Lewis Au may publish in the future.

Co-authorship network of co-authors of Lewis Au

This figure shows the co-authorship network connecting the top 25 collaborators of Lewis Au. A scholar is included among the top collaborators of Lewis Au based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lewis Au. Lewis Au is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Udovicich, Cristian, Mathias Bressel, Jamil Manji, et al.. (2025). PSMA-Guided Metastasis-Directed Therapy for Oligometastatic Renal Cell Carcinoma: The Proof-of-Concept PEDESTAL Study. Journal of Nuclear Medicine. 66(4). 531–536. 2 indexed citations
3.
Au, Lewis, Zayd Tippu, Husayn Ahmed Pallikonda, et al.. (2025). Vasculo-immune modulatory effects of anti-VEGF therapy in metastatic clear cell renal cell carcinoma: The A-PREDICT trial.. Journal of Clinical Oncology. 43(5_suppl). 572–572. 1 indexed citations
4.
Eifer, Michal, Duncan E. K. Sutherland, Isaac Goncalves, et al.. (2025). Therapy-Related Myeloid Neoplasms After [177Lu]Lu-PSMA Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Series. Journal of Nuclear Medicine. 66(4). 579–584. 4 indexed citations
5.
Eapen, Renu, Scott Williams, Sean Macdonald, et al.. (2024). Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer. Nature Reviews Urology. 21(11). 676–686. 6 indexed citations
6.
Desai, Jayesh, et al.. (2024). Bispecific antibodies: advancing precision oncology. Trends in cancer. 10(10). 893–919. 53 indexed citations breakdown →
7.
Pietro, Andrea Di, Lewis Au, Patricia Crock, et al.. (2024). Abstract A006: Tissue resident memory (TRM) T cells and dendritic cells form an in situ archetype for improved response to immune checkpoint therapy in metastatic melanoma. Cancer Immunology Research. 12(10_Supplement). A006–A006. 1 indexed citations
8.
Joshi, Kroopa, et al.. (2023). TCR sequencing: applications in immuno-oncology research. Immuno-Oncology Technology. 17. 100373–100373. 9 indexed citations
9.
Dearden, Helen Clare, Lewis Au, Daniel Wang, et al.. (2021). Hyperacute toxicity with combination ipilimumab and anti-PD1 immunotherapy. European Journal of Cancer. 153. 168–178. 24 indexed citations
10.
Fendler, Annika, Lewis Au, Fiona Byrne, et al.. (2021). 1557O Adaptive immunity to SARS-CoV-2 infection and vaccination in cancer patients: The CAPTURE study. Annals of Oncology. 32. S1129–S1129. 10 indexed citations
11.
Gudd, Cathrin, Lewis Au, Evangelos Triantafyllou, et al.. (2021). Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis. Journal of Hepatology. 75(1). 177–189. 43 indexed citations
12.
Fendler, Annika, Lewis Au, Scott T.C. Shepherd, et al.. (2020). CAPTURE: Cancer and COVID-19 antiviral immune monitoring study. Clinical Cancer Research. 26(18).
13.
Au, Lewis, Laura Boos, Anthony J. Swerdlow, et al.. (2020). Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study. Cell. 183(1). 4–10. 22 indexed citations
14.
Spain, Lavinia, Lewis Au, James J. Clark, et al.. (2020). Five-year review of corticosteroid duration and complications in the management of immune checkpoint inhibitor-related diarrhoea and colitis in advanced melanoma. ESMO Open. 5(4). e000585–e000585. 30 indexed citations
15.
Tippu, Zayd, Lewis Au, & Samra Turajlic. (2020). Evolution of Renal Cell Carcinoma. European Urology Focus. 7(1). 148–151. 18 indexed citations
16.
O’Reilly, Aine, Jhia Jiat Teh, Emma McLean, et al.. (2019). An immunotherapy survivor population: health-related quality of life and toxicity in patients with metastatic melanoma treated with immune checkpoint inhibitors. Supportive Care in Cancer. 28(2). 561–570. 52 indexed citations
17.
Brown, Rachel, Lewis Au, Lavinia Spain, et al.. (2019). 208 Immune checkpoint inhibitor-related neurotoxicity: a case series. Journal of Neurology Neurosurgery & Psychiatry. 90(12). e52.3–e52. 1 indexed citations
18.
Mason, Robert M., Lewis Au, Alvaro Ingles Garces, & James Larkin. (2019). Current and emerging systemic therapies for cutaneous metastatic melanoma. Expert Opinion on Pharmacotherapy. 20(9). 1135–1152. 34 indexed citations
19.
Larkin, James, Donald M. Cannon, Lewis Au, et al.. (2018). Real-World EQ-5D-5L Utility Values In Patients With Melanoma Derived Using A Digital ‘Bring Your Own Device’ Platform. Value in Health. 21. S36–S36.
20.
Haydon, Andrew, Lewis Au, Simon Wilkins, et al.. (2018). Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres. International Journal of Surgery. 51. 71–75. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026